Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Cheng%2C+Shu-Hsing%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Cheng%2C+Shu-Hsing%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Cheng%2C+Shu-Hsing%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (32)
1
Author Correction : Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
enthalten in:
Nature communications
| 2024
von
Axfors, C.
|
Schmitt, A.
|
Janiaud, P.
| +91
ErratumFor: Nat Commun. 2021 Apr 15;12(1):2349. - PMID 33859192
Wird geladen...
2
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection : A convalescent cohort study in Taiwan
enthalten in:
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
| 2023
von
Huang, Y.
|
Hsu, F.
|
Wu, J.
| +17
Wird geladen...
3
Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation
enthalten in:
Journal of clinical virology plus
| 2023
von
Chao, T.
|
Lee, W.
|
Hu, H.
| +12
Wird geladen...
4
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV
enthalten in:
Vaccines
| 2022
von
Cheng, S.
|
Lien, C.
|
Hsieh, S.
| +15
Wird geladen...
5
Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants
enthalten in:
bioRxiv.org
| 2022
von
Chen, C.
|
Huang, K.
|
Shih, S.
| +5
Wird geladen...
6
Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222
enthalten in:
Vaccines
| 2022
von
Cheng, S.
|
Lin, Y.
|
Chen, C.
| +1
Wird geladen...
7
Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants
enthalten in:
Microbiology spectrum
| 2022
von
Chen, C.
|
Huang, K.
|
Shih, S.
| +5
Wird geladen...
8
An Immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
enthalten in:
bioRxiv.org
| 2022
von
Estrada, J.
|
Cheng, C.
|
Ku, S.
| +6
Wird geladen...
9
An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
enthalten in:
Vaccines
| 2022
von
Estrada, J.
|
Cheng, C.
|
Ku, S.
| +7
Wird geladen...
10
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
enthalten in:
Journal of the Formosan Medical Association = Taiwan yi zhi
| 2022
von
Sheng, W.
|
Chang, S.
|
Lin, P.
| +10
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
32
Aufsätze
32
E-Artikel
32
E-Ressourcen
Zeitschriftentitel
9
bioRxiv.org
4
Journal of microbiology, immunology, and infect...
3
Nature communications
3
Vaccines
2
PLoS pathogens
1
Biomedical journal
1
Emerging microbes & infections
1
International journal of infectious diseases : ...
1
Journal of clinical virology plus
1
Journal of global antimicrobial resistance
1
Journal of the Formosan Medical Association = T...
1
Microbiology spectrum
1
Nature structural & molecular biology
1
PloS one
1
The Lancet. Respiratory medicine
1
Theranostics
Alle anzeigen ...
weniger ...
Thema
19
Journal Article
8
Antibodies, Viral
8
COVID-19
8
Research Support, Non-U.S. Gov't
6
Antibodies, Neutralizing
6
SARS-CoV-2
5
Multicenter Study
4
Angiotensin-Converting Enzyme 2
4
EC 3.4.17.23
4
Spike Glycoprotein, Coronavirus
4
spike protein, SARS-CoV-2
3
ACE2 protein, human
3
Epitopes
3
Published Erratum
2
4QWG6N8QKH
2
886U3H6UFF
2
Antibodies, Monoclonal
2
COVID-19 Vaccines
2
COVID-19 vaccine
2
Case Reports
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
2
2023
9
2022
12
2021
8
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
32
Englisch
Haven't found what you're looking for?
Wird geladen...